文献速递慢性肾脏病急性肾损伤

FSTL3在肾功能不全中升高

FSTL3 is increased in renal dysfunction.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

在581例CKD患者(eGFR G1至G5)和61例择期单侧肾切除术前及术后30小时内患者中检测循环FSTL3,发现中位FSTL3随肾功能恶化持续升高(G1 6.1至G5 32.1 µg/L,P<0.001),肾功能为独立预测因子,CKD小鼠肝脏mFSTL3 mRNA较对照升高逾6倍。

要点

  • 循环FSTL3随eGFR分级恶化而持续升高,G1为6.1 µg/L,G5为32.1 µg/L(P<0.001)。
  • 在CKD和AKD患者中,肾功能均为FSTL3血清浓度的最强独立预测因子。
  • CKD小鼠肝脏mFSTL3 mRNA表达较对照升高逾6倍。

核心结论

  • 循环FSTL3在CKD和AKD患者中与肾功能显著且独立相关。
  • 肝脏mFSTL3 mRNA上调可能促成CKD中FSTL3水平升高。
  • 结果与FSTL3由肾脏清除并可能对抗肾功能不全中观察到的有害激活素/肌肉生长抑制素信号这一假说一致。

研究设计与样本

  • 采用酶联免疫吸附法在581例涵盖eGFR G1至G5全谱的CKD患者中定量循环FSTL3。
  • 在61例择期单侧肾切除术患者术前及术后30小时内测量FSTL3,作为AKD模型。
  • 在eNOS-/-db/db小鼠CKD模型中检测mFSTL3 mRNA表达,并与同窝对照比较。

主要发现

  • 中位循环FSTL3水平随肾功能恶化显著且持续升高:G1 6.1、G2 8.2、G3 12.7、G4 18.5、G5 32.1 µg/L(P<0.001)。
  • 在CKD和AKD患者的多变量分析中,肾功能均为FSTL3血清浓度的最强独立预测因子。
  • FSTL3与不良心血管代谢特征独立相关。
  • CKD小鼠肝脏mFSTL3 mRNA表达较对照升高逾6倍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Follistatin-like 3 (FSTL3) is a novel cytokine that regulates insulin sensitivity and counteracts activin/myostatin signalling. In the present study, regulation of FSTL3 in renal dysfunction was investigated in both human chronic kidney disease (CKD) and acute kidney dysfunction (AKD). Furthermore, mFSTL3 expression was analysed in insulin-sensitive tissues in a mouse model of CKD. METHODS: Circulating FSTL3 was quantified by enzyme-linked immunosorbent assay in 581 patients with CKD covering the whole spectrum of estimated glomerular filtration rate (eGFR) categories from G1 to G5. Furthermore, FSTL3 was measured in 61 patients before and within 30 h after elective unilateral nephrectomy, an established model of AKD. Moreover, mFSTL3 mRNA expression was investigated in an animal CKD model, that is, eNOS-/-db/db mice, and compared with littermate controls. RESULTS: Median circulating FSTL3 levels significantly and continuously increased with deteriorating renal function (eGFR category G1: 6.1; G2: 8.2; G3: 12.7; G4: 18.5; G5: 32.1 µg/L; P < 0.001). In both human CKD and AKD, renal dysfunction remained the strongest independent predictor of FSTL3 serum concentrations in multivariate analyses. FSTL3 was independently associated with an adverse cardiometabolic profile. In CKD mice, hepatic mFSTL3 mRNA expression was increased more than 6-fold as compared with controls. CONCLUSIONS: Circulating FSTL3 is significantly and independently associated with renal function in both patients with CKD and AKD. Hepatic mFSTL3 mRNA upregulation might contribute to increased FSTL3 levels in CKD. Our results are in agreement with the hypothesis that FSTL3 is eliminated by the kidneys and might counteract adverse activin/myostatin signalling observed in renal dysfunction.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kralisch S, Hoffmann A, Klöting N, et al. FSTL3 is increased in renal dysfunction. Nephrol Dial Transplant. 2017. PMID: 28339962. doi:10.1093/ndt/gfw472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。